MedPath

Microbiotica Ltd.

Microbiotica Ltd. logo
🇬🇧United Kingdom
Ownership
Holding
Established
2016-12-01
Employees
11
Market Cap
-
Website
http://www.microbiotica.com

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

Phase 1
Recruiting
Conditions
Ulcerative Colitis
Interventions
First Posted Date
2024-09-03
Last Posted Date
2025-02-21
Lead Sponsor
Microbiotica Ltd
Target Recruit Count
30
Registration Number
NCT06582264
Locations
🇦🇹

Medizinische Universitaet Innsbruck, Innsbruck, Austria

🇦🇹

Klinikum Klagenfurt am Woerthersee, Klagenfurt, Austria

🇦🇹

Uniklinikum Salzburg, Salzburg, Austria

and more 15 locations

A Phase 1b Trial to Evaluate Safety of MB097 in Combination with Pembrolizumab in Melanoma Patients

Phase 1
Recruiting
Conditions
Melanoma
Interventions
First Posted Date
2024-08-06
Last Posted Date
2025-02-07
Lead Sponsor
Microbiotica Ltd
Target Recruit Count
40
Registration Number
NCT06540391
Locations
🇫🇷

Centre Georges Francois Leclerc, Dijon, France

🇫🇷

CHU de Lille - Hopital Claude Huriez, Lille, France

🇫🇷

Centre Leon Berard, Lyon, France

and more 16 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath